FDA considers expanding indication for Cymbalta; side effects SJS, TEN
A Food and Drug Administration (FDA) advisory committee has narrowly voted to recommend that the indication for Eli Lilly’s antidepressant Cymbalta (duloxetine) be expanded to include use as a treatment for chronic musculoskeletal pain. The Anesthetic and Life Support Drugs Advisory Committee also voted that the benefits were minimal but outweighed the risks, which includes a black box warning of suicidality in children, adolescents and young adults; a potential for liver damage; and a risk of developing the rare skin disease Stevens Johnson Syndrome (SJS) and its more serious form, toxic epidermal necrolysis (TEN).

Kisandra said she felt like a lab rat the day a team of doctors studied the blisters that had sprung up all over her body and pored through thick medical books trying to find what had made her sick. She had just been given Biaxin, an antibiotic, to treat a stomach ulcer. Shortly after starting the medication she developed a fever and blisters on her face, arms, torso and hands.
The Centers for Disease Control (CDC) is warning the public about a medication used to treat a type of glaucoma because users could develop a serious and life threatening
Famotidine, the heartburn drug most known by the brand name Pepcid, is yet another drug that has been linked to a deadly skin reaction known as